piritrexim has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carabasi, M; Casper, E; Cheng, E; Clendeninn, NJ; Feyzi, J; Magill, G; Marks, L; Schiesel, JD; Smalley, RV | 1 |
| Adamson, PC; Arndt, C; Aronson, L; Balis, FM; Clendeninn, NJ; Gillespie, A; Miser, J; Penta, JS; Poplack, DG; Wells, RJ | 1 |
2 trial(s) available for piritrexim and Sarcoma
| Article | Year |
|---|---|
Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Folic Acid Antagonists; Humans; Male; Middle Aged; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 1992 |
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Leukocyte Count; Male; Neoplasms; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sarcoma | 1992 |